Manufacturing News of Note—New cell therapy facility in China

stock market
(Pixabay)

> Chinese biotech Cellular Biomedicine Group is building a cell therapy facility at its site in Shanghai and will use a GE Healthcare FlexFactory to speed the process. Release 

> Excipient maker Colorcon will build a new starch manufacturing plant near Amsterdam. Story

> ADC Bio has added a WHP cleanroom to its 6,500-square-meter bioconjugation facility at its new site in Deeside, North Wales, in the U.K. Story

Survey

Survey: The Critical Role of Innovation in Launching Successful OTC Products

This research aims to understand the importance of product innovation and dose forms in driving new product design and development, consumer engagement and purchase interest for Over-the-Counter medicines. The first 50 qualified respondents will receive a $5 Amazon gift card. Take the survey now.

Suggested Articles

Neopharma, which has been buying and building plants for several years, is buying a sterile injectables plant and assets in Japan from India’s Lupin. 

Already knocked by the FDA four times this year, Dr. Reddy’s now has a fifth Form 483 to dwell on. This time it’s at a plant with a history of faults.

In a warning letter, the FDA details how a Chinese OTC drugmaker handed over documents faked just for the agency's inspection—and admitted it.